Skip to main content
OpenTrials

Clinical trial condition

Neoplastic Processes

Explore clinical trials studying Neoplastic Processes. Study availability and eligibility vary by location and protocol.

3,267 public trials 689 recruiting studies
Refine in advanced search Browse all conditions

Neoplastic Processes trial results

Completed

PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 Mutation

NCT05639751

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +6 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCLA Hematology/Oncology - Santa Monica Santa Monica, California, United States
  • Smilow Cancer Hospital Phase 1 Unit New Haven, Connecticut, United States
  • AdventHealth Medical Group Oncology Research at Celebration Celebration, Florida, United States
View all 32 locations
View Trial Details
Completed

A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors

NCT05082610

Conditions
Advanced Solid Tumor, Breast Diseases, Breast Neoplasms, +23 more
Locations
  • The City of Hope National Medical Center Duarte, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Smilow Cancer Hospital - Yale New Heaven Health New Haven, Connecticut, United States
View Trial Details
Completed

A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT05271604

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +13 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Christiana Care Helen Graham Cancer Center Newark, Delaware, United States
  • Northwestern University Chicago, Illinois, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
View Trial Details
Completed

Dose Escalation Trial of BNT152+153 in Patients With Cancer

NCT04710043

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Duke Cancer Center Durham, North Carolina, United States
  • Sarah Cannon Research Institute at Tennessee Oncology Nashville, Tennessee, United States
View Trial Details

Related conditions